Skye Bioscience (SKYE) Insider Trading & Ownership $3.44 -0.11 (-2.96%) As of 02:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Skye Bioscience (NASDAQ:SKYE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$2.91M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SKYE Insider Buying and Selling by Quarter Skye Bioscience Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Kaitlyn ArsenaultCFOSell43,206$4.99$215,597.94 11/18/2024Paul A GraysonDirectorSell86,244$4.99$430,357.56 11/18/2024Punit DhillonCEOSell82,546$4.99$411,904.54 11/18/2024Tuan Tu DiepInsiderSell19,489$4.99$97,250.11 11/15/2024Kaitlyn ArsenaultCFOSell190$5.55$1,054.50 11/15/2024Paul A GraysonDirectorSell307$5.55$1,703.85 11/15/2024Punit DhillonCEOSell364$5.55$2,020.20 11/15/2024Tuan Tu DiepInsiderSell85$5.55$471.75 9/13/2024Andrew J SchwabDirectorSell13,837$6.06$83,852.22 9/11/2024Andrew J SchwabDirectorSell252,500$6.60$1,666,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) SKYE Insider Trading Activity - Frequently Asked Questions Who is on Skye Bioscience's Insider Roster? The list of insiders at Skye Bioscience includes Andrew J Schwab, Kaitlyn Arsenault, Paul A Grayson, Punit Dhillon, and Tuan Tu Diep. Learn more on insiders at SKYE. What percentage of Skye Bioscience stock is owned by insiders? 4.50% of Skye Bioscience stock is owned by insiders. Learn more on SKYE's insider holdings. Which Skye Bioscience insiders have been selling company stock? The following insiders have sold SKYE shares in the last 24 months: Andrew J Schwab ($1,750,352.22), Kaitlyn Arsenault ($216,652.44), Paul A Grayson ($432,061.41), Punit Dhillon ($413,924.74), and Tuan Tu Diep ($97,721.86). How much insider selling is happening at Skye Bioscience? Insiders have sold a total of 498,768 Skye Bioscience shares in the last 24 months for a total of $2,910,712.67 sold. Skye Bioscience Key ExecutivesMr. Punit S. Dhillon B.A. (Age 44)Executive Chairman, President, CEO & Secretary Compensation: $720kDr. Christopher G. Twitty Ph.D. (Age 51)Chief Scientific Officer Mr. Tu Diep M.Sc. (Age 43)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Gossamer Bio Insider Transactions Erasca Insider Transactions Compass Therapeutics Insider Transactions Palvella Therapeutics Insider Transactions REGENXBIO Insider Transactions Tectonic Therapeutic Insider Transactions Kodiak Sciences Insider Transactions Fulcrum Therapeutics Insider Transactions COMPASS Pathways Insider Transactions Aquestive Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:SKYE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
